Unlike finasteride, which is not approved for women, copper peptides work through non-hormonal pathways: Follicle enlargement via Wnt/beta-catenin signalling Improved scalp circulation via angiogenesis Anti-inflammatory protection reducing follicle miniaturisation Women experiencing diffuse thinning, post-partum shedding, or early-stage androgenetic alopecia can all benefit from regular use
(2026) Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans
There are not thought to be acute side-effects from injecting NAD+ which, if it is not absorbed, is expelled in urine
Prevention is not supported, womens health is underfunded and under-researched, and too many conversations about weight, and similarly hormones and mental health, are soaked in stigma
& Wimley, W
Specific scheduling belongs in a clinical conversation with your prescribing provider